JENNIFER TRIPP
FORM 1023-EZ for SHOOT FOR THE CURE FUND
WEBSITE: HTTP://WWW.ARLINGTONSHOOTFORTHECURE.COM/SHOOT FOR THE CURE FUND is a based in ARLINGTON, MA, focused on Diseases, Disorders, Medical Disciplines causes , specifically Cancer. Established in June 2015, it operates as an independent corporation and contributions to this organization are tax-deductible .
With total assets of $0.00, this ranks 1,803,586 among 2,656,690 nonprofits nationally (Top 68%), demonstrating developing financial capacity relative to its peers. At the state level, it stands at 27,667 out of 58,562 organizations in MA (Top 48%).
In middlesex county, MA, the organization ranks 11,426 out of 14,370 nonprofits by assets (Top 80%), while locally in arlington, it stands at 287 among 361 organizations (Top 76%).
The organization reported no revenue in the most recent filing period, placing it at 695,027 nationally and 27,439 in MA.
Within its specific NTEE classification (G30 - G: Diseases, Disorders, Medical Disciplines), which includes 3,218 similar organizations, SHOOT FOR THE CURE FUND ranks 1,344 in assets (Top 42%) and 1,245 in revenue (Top 39%).
Note: This organization's tax-exempt status was temporarily revoked on May 15, 2023 .
The organization files a 990 - Required to file Form 990-N - Income less than $25,000 per year and operates on a November fiscal year. Additional information can be found at HTTP://WWW.ARLINGTONSHOOTFORTHECURE.COM/.
IRS STATEMENT:
"Important note: Just because an organization appears on this list, it does not
mean the organization is currently revoked, as they may have been reinstated."
You may confirm an organization's status by calling the IRS (toll-free) at 1-877-829-5500.
Disclaimer: While we are confident of the accuracy of the information on this page, we encourage you verify the information directly with IRS. The IRS has a toll-free number for this at 1-877-829-5500 or visit www.irs.gov.
Login to:
Register to:
Use the link provided to create your password, log in, and gain access to the 501c3 Lookup platform.